Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations

Regulatory changes have been enacted in the United States (US) and European Union (EU) to encourage the development of new treatments for pediatric cancer. Here, we review some of the factors that have hampered the development of pediatric cancer treatments and provide a comparison of the US and EU...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Paediatr Drugs
Autores principales: Barry, Elly, Walsh, Jaimie A., Weinrich, Scott L., Beaupre, Darrin, Blasi, Eileen, Arenson, Daniel R., Jacobs, Ira A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8275539/
https://ncbi.nlm.nih.gov/pubmed/34173206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-021-00455-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares